logo
Impact Radar
  • Overview
  • Impact Performance
  • Compare this company
  • All sources
    • Sign UpLog In
    logo

    Dermapharm Share | Sustainability & Chart

    DE000A2GS5D8

    Basic information on the Dermapharm Share

    Location: Germany

    Industry: Manufacturing

    Website

    knob-globe
    43%

    Impact Score

    Description Dermapharm Share

    Dermapharm is a German pharmaceutical company focusing on the manufacturing and distribution of patent-free drugs and health products.

    Dermapharm Share Sustainability Performance

    Renewable Energy
    Greenhouse Gas Emissions
    Supply Chain
    Waste Recycling
    Sustainable
    Not yet sustainable
    Not sustainable
    No data
    We measure the sustainability of companies based on 12 criteria. Learn more about our method.

    Compare Dermapharm with ...

    Dermapharm

    ?

    Impact Score

    knob-globe
    43%
    knob-globe
    0%
    Climate
    Society
    Gender

    Sources of sustainability performance

    MetricValueUnitYearPDF NamePDF Page
    CEO-to-Employee Pay Ratio
    Total wages paid264 480EUR thousand2023Dermapharm_AnnualReport2023_en_locked.pdf143
    CEO salary1 375EUR thousand2023Dermapharm_AnnualReport2023_en_locked.pdf176
    Number of employees3 497employees2023Dermapharm_AnnualReport2023_en_locked.pdf36
    CEO nameHans-Georg Feldmeier2023Dermapharm_AnnualReport2023_en_locked.pdf6
    Employee turnover rate
    Employee turnover9,6%2023DERMAPHARM_CSR-Bericht2023_en_locked.pdf44
    Glass Ceiling
    Women in management48%2023Dermapharm_AnnualReport2023_en_locked.pdf90
    Women in workforce58,2%2023DERMAPHARM_CSR-Bericht2023_en_locked.pdf44
    Harassment and Discrimination at the Workplace
    Confidentiality mechanismsNeutral2023Dermapharm_AnnualReport2023_en_locked.pdf73
    Incident notification mechanismYes2023Dermapharm_AnnualReport2023_en_locked.pdf73
    Anti-discrimination policyYes2023Dermapharm_AnnualReport2023_en_locked.pdf64
    Retaliation safeguardsYes2023Code_of_Conduct_of_the_Dermapharm_Group.pdf3
    Union Formation and Collective Bargaining Power
    Collective bargaining agreements coverage13,6%2023DERMAPHARM_CSR-Bericht2023_en_locked.pdf41
    Women on the Board
    Women on supervisory board1Members2023Dermapharm_AnnualReport2023_en_locked.pdf158
    Supervisory board size4Members2023Dermapharm_AnnualReport2023_en_locked.pdf158
    Executive board size3Members2023Dermapharm_AnnualReport2023_en_locked.pdf158
    Women on executive board0Members2023Dermapharm_AnnualReport2023_en_locked.pdf158
    Women in Management
    Women in management48%2023Dermapharm_AnnualReport2023_en_locked.pdf90
    Note: The PDF pages given here refer to the page in the PDF document, which is not necessarily the one found in the footer of the page. For example, page 10 is the 10th page in the document, even if it is labeled as page 8.

    Find more sustainable shares

    logo
    HomeFind Stocks & ETFsLearn to investAcademyGlossaryOur Method
    ImprintPrivacy PolicyGTCFAQContact UsAbout Us
    © 2025 money:care GmbHDisclaimerThe information provided is for informational purposes only and does not constitute an offer, recommendation, or investment advice to buy or sell financial instruments. Nor may they or any part of them be used as a basis for concluding a contract. They have been adopted in good faith from publicly accessible sources. No liability can be assumed for their accuracy. Any financial instrument referred to in this information and documents may be unsuitable for the respective investor to whom it is addressed. The recipients of such information and documents are responsible for independently evaluating and reviewing the products, assets, and financial instruments mentioned therein. Investors must make their own assessment of the suitability of the financial instruments mentioned herein based on the benefits and risks associated with the acquisition of the products, as well as on the basis of their own investment strategy and their legal, tax, and financial situation. Should readers use the content offered or follow any advice, they act on their own responsibility.The source of ETF data is the websites and data sheets of the respective ETF providers.Logos provided by Clearbit (https://clearbit.com/). All trademarks and logos appearing on this website are the property of their respective owners and are used here for informational and educational purposes only, under fair use guidelines. We claim no affiliation with, nor endorsement by, the companies whose trademarks and logos are displayed. This website is independent of the brands analyzed and receives no direct or indirect compensation from them.The information contained in the company descriptions is generated by artificial intelligence and is for informational purposes only. While we strive for accuracy, the content may not be entirely reliable or comprehensive. We recommend cross-referencing the AI-generated content with other reliable sources to verify it and gain a more comprehensive understanding of the respective companies.Some links are affiliate links. If you click on these links and open an account, we will receive a small commission. Don't worry, you won't incur any additional costs. Thank you for your support!